Meyka Pro banner
CapsoVision, Inc.

CapsoVision, Inc. (CV) Stock Overview

Explore CapsoVision, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CVNASDAQ
HealthcareMedical - Devices
$5.99
$0.02(0.34%)
U.S. Market opens in NaNh NaNm

CapsoVision, Inc. (CV)

Meyka AI Score

Z

Key Financials

Market Cap299.3M
P/E Ratio-9.57
EPS (TTM)$-2.50
ROE-1.78%
Fundamental Analysis

AI Price Forecasts

1 Month$7.11
3 Months$8.04
1 Year Target$13.24

CV Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CapsoVision, Inc. (NASDAQ: CV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CapsoVision, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CV on the NASDAQ shows an RSI of 43.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $13.24 for the NASDAQ listing.

Key metrics behind CapsoVision, Inc.'s NASDAQ-traded stock include a P/E ratio of -9.57 and a market capitalization of 299.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CV on the NASDAQ.

Price Performance (NASDAQ: CV)

1-Day Change
0.34%
5-Day Change
-2.28%
1-Month Change
-13.69%
3-Month Change
-20.56%
6-Month Change
15.41%
Year-to-Date (YTD) Change
-43.97%
1-Year Change
58.47%
3-Year Change
71.14%
5-Year Change
71.14%
All-Time (Max) Change
71.14%

Contact Information

14086241488
18805 Cox Avenue, Saratoga, CA, 95070

Company Facts

990 Employees
IPO DateJul 2, 2025
CountryUS
Actively Trading

Frequently Asked Questions